Rtog Foundation, Inc.

This study is for people whose head and neck cancer has come back or who have a new, related cancer in the same area. It is testing whether adding an immunotherapy drug (pembrolizumab/Keytruda) to a short, precise course of radiation is better at keeping the cancer from growing a…

This study is for men whose prostate cancer has started to return after surgery, showing aggressive features. It compares two treatment approaches: standard radiation plus hormone therapy versus the same radiation plus a stronger, two-drug hormone therapy. The goal is to see if t…